Skip to content

A Study Assessing Circulation Around Surgical Incisions at the Time of Laparotomy Closure

Feasibility of Assessing Wound Perfusion at the Time of Laparotomy Closure

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03408366
Enrollment
20
Registered
2018-01-24
Start date
2018-01-15
Completion date
2022-08-01
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Laparotomy

Keywords

Laparotomy, Surgical Incisions, Wound Perfusion, 17-650

Brief summary

This study is being done to find out if Spectrum Near-Infrared (NIR) imaging with Indocyanine Green (ICG) dye can help measure blood flow around an incision before and after the surgeon closes the incision with staples or sutures. The Spectrum NIR imaging system uses a handheld camera that produces a special type of light that can help surgeons see things during surgery that are difficult to see with the naked eye, for example, cancer tissue versus healthy tissue. Spectrum NIR imaging has been approved by the Food and Drug Administration (FDA) as a tool that is widely used during surgery. ICG dye is a sterile solution that can be seen with Spectrum NIR imaging. This dye, used with Spectrum NIR imaging, allows surgeons to see blood flow to parts of the body during and after surgery. Making sure that there is enough blood flow to the surgical site helps to promote a less complicated recovery.

Interventions

PROCEDURELaparotomy

Laparotomy via vertical midline incision and after the planned surgical procedure is complete.

OTHERICG

ICG will be injected intravenously ICG is a fluorescent iodide dye.

OTHERSpectrum NIR imaging system

The Spectrum NIR imaging system uses a handheld camera that emits light in the NIR range.

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Twenty consecutive patients will be enrolled: the first 10 will have skin closure with staples, and the second 10 will have skin closure with a running subcuticular suture.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Criteria for Eligibility Prior to Surgery Inclusion Criteria: * Woman undergoing a laparotomy procedure via a vertical midline incision for any indication with the Gynecology Service at MSK * Age ≥18 years

Exclusion criteria

* Women with hepatic dysfunction as evidenced by elevated transaminases * Women with a history of cirrhosis or other chronic liver disease * Women with an allergy to iodine * Women undergoing laparoscopic or minimally invasive surgery Criteria for Eligibility Post-Surgery Inclusion Criteria: * Woman undergoing a laparotomy procedure via a vertical midline incision for any indication with the Gynecology Service at MSK * Age ≥18 years Subject

Design outcomes

Primary

MeasureTime frameDescription
percentage of cases with successful perfusion measurements1 yearFeasibility will be determined by the percentage of cases with successful perfusion measurements.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026